Allkem Limited
ASX:AKE.AX
9.83 (AUD) • At close December 21, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2012 Q2 | 2012 Q1 | 2011 Q4 | 2011 Q3 | 2011 Q2 | 2011 Q1 | 2010 Q4 | 2010 Q3 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 640.735 | 486.08 | 567.518 | 436.119 | 5.38 | 2.442 | 0.249 | 0.345 | 0 | 0 | 0.674 | 0.332 |
Cost of Revenue
| 112.341 | 34.539 | 130.292 | 74.907 | 4.949 | 2.187 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 528.395 | 451.541 | 437.226 | 361.212 | 0.431 | 0.255 | 0.249 | 0.345 | 0 | 0 | 0.674 | 0.332 |
Gross Profit Ratio
| 0.825 | 0.929 | 0.77 | 0.828 | 0.08 | 0.104 | 1 | 1 | 0 | 0 | 1 | 1 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 27.724 | 27.621 | 21.695 | 23.092 | 3.543 | 1.171 | 0.621 | 0.966 | 0 | 1.041 | 0.865 | 0.833 |
Selling & Marketing Expenses
| 35.003 | 34.872 | 16.518 | 17.582 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 81.419 | 62.493 | 52.17 | 40.674 | 3.543 | 1.171 | 0.621 | 0.966 | 0 | 1.041 | 0.865 | 0.833 |
Other Expenses
| -11.709 | 0 | -8.716 | 0 | 0 | 0 | -0.153 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 93.128 | 145.817 | 60.887 | 77.826 | 3.543 | 1.171 | 0.468 | 0.966 | 0 | 1.041 | 0.865 | 0.833 |
Operating Income
| 435.267 | 330.359 | 376.34 | 288.674 | -3.112 | -0.916 | -0.219 | -0.621 | 0 | -1.041 | -0.577 | -0.116 |
Operating Income Ratio
| 0.679 | 0.68 | 0.663 | 0.662 | -0.578 | -0.375 | -0.88 | -1.799 | 0 | 0 | -0.856 | -0.348 |
Total Other Income Expenses Net
| -41.631 | 7.283 | -9.682 | 7.181 | 106.735 | 0.318 | -0.026 | 0.058 | 0 | 0.078 | 0.27 | -0.013 |
Income Before Tax
| 443.16 | 337.642 | 389.116 | 295.856 | 103.624 | -0.598 | -0.245 | -0.563 | 0 | -0.963 | -0.307 | -0.128 |
Income Before Tax Ratio
| 0.692 | 0.695 | 0.686 | 0.678 | 19.26 | -0.245 | -0.986 | -1.631 | 0 | 0 | -0.455 | -0.386 |
Income Tax Expense
| 147.279 | 111.73 | 158.636 | 121.906 | -0.1 | -0.019 | 0.686 | -0.03 | 0 | -0.016 | -0.379 | 0.371 |
Net Income
| 257.629 | 195.444 | 183.505 | 143.58 | 103.764 | -0.58 | -0.931 | -0.533 | 0 | -0.948 | 0.072 | -0.499 |
Net Income Ratio
| 0.402 | 0.402 | 0.323 | 0.329 | 19.286 | -0.237 | -3.741 | -1.544 | 0 | 0 | 0.107 | -1.504 |
EPS
| 0.4 | 0.3 | 0.29 | 0.22 | 0.97 | -0.006 | -0.009 | -0.005 | 0 | -0.009 | -0.001 | -0.005 |
EPS Diluted
| 0.4 | 0.3 | 0.29 | 0.22 | 0.97 | -0.006 | -0.009 | -0.005 | 0 | -0.009 | -0.001 | -0.005 |
EBITDA
| 502.079 | 372.057 | 409.156 | 313.841 | -4.266 | -1.234 | -0.193 | -0.679 | 0 | -1.119 | -0.846 | -0.488 |
EBITDA Ratio
| 0.784 | 0.765 | 0.721 | 0.72 | -0.793 | -0.506 | -0.774 | -1.967 | 0 | 0 | -1.256 | -1.472 |